The IOZK treatment centre

 

The autologous cell therapy was developed over many years by the doctors and scientists at the Immune Oncology Centre in Cologne. As a form of compassionate-use treatment, it has been used to treat over 1.000 patients with different types of cancer.
In 2016, the IOZK was awarded a manufacturing authorisation for an autologous (patient-specific) tumour vaccine used in combination with an oncolytic virus according to the Medicines Act for advanced therapy medicinal products, a first in Europe.
Please contact the team at the IOZK in Cologne if you have any further questions about our immune therapy for cancer.

 

Immun-Onkologisches Zentrum Köln

Hohenstaufenring 30-32

50674 Cologne

Germany

 

Phone: +49 (0)221 42039925

E-Mail: info(at)iozk.de

 

www.iozk.de

DE 

|

Delta-Vir Klinische Studien